HIV and COVID-19 Increased Risk of Severe Outcomes

HIV and COVID-19 Increased Risk of Severe Outcomes

People living with HIV with detectable HIV viraemia, chronic comorbidities, and some subpopulations could be at increased risk of severe outcomes from COVID-19. These groups should be prioritised in clinical management and... read more

COVID-19-related Death in Fully Vaccinated People in Scotland – Characteristics and Risk

COVID-19-related Death in Fully Vaccinated People in Scotland – Characteristics and Risk

Vaccines are highly effective in preventing COVID-19 hospitalisations and deaths. COVID-19-related deaths in fully vaccinated individuals have, however, been reported. To inform public health strategy and vaccination... read more

Suboptimal COVID-19 Vaccination Coverage Implications in Florida and Texas

Suboptimal COVID-19 Vaccination Coverage Implications in Florida and Texas

In July, 2021, another wave of COVID-19 began in the USA as the highly infectious delta (B.1.617.2) SARS-CoV-2 variant drove outbreaks predominantly affecting states with relatively low vaccination coverage. Some US states... read more

COVID-19 Immune Evasion by the B.1.427/B.1.429 Variant of Concern

COVID-19 Immune Evasion by the B.1.427/B.1.429 Variant of Concern

As battles to contain the COVID-19 pandemic continue, attention is focused on emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that have been deemed variants of concern because they... read more

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

This study presents the first evidence that full vaccination against COVID-19 suppresses emergent mutations of SARS-CoV-2 delta variants. An evolution algorithm, Tajima's D test with a threshold value as -2.50, can provide... read more

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

A group of junior doctors from Scotland have written to young people in their age group to try to ease concerns they may have about receiving the covid-19 vaccine. In an open letter sent on Friday 6 August the doctors,... read more

Moderna Vaccine 94.1% Efficacy Preventing Symptomatic COVID-19

Moderna Vaccine 94.1% Efficacy Preventing Symptomatic COVID-19

The SARS-CoV-2 pandemic continues to be a global health concern. The mRNA-1273 (Moderna) vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-19 due to infection with ‘wild-type’ variants... read more

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination

This study found an association between vaccination with BNT162b2 in hospital employees and a decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2. Limitations include the observational design; short... read more

Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Johnson & Johnson Vaccination

Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Johnson & Johnson Vaccination

The initial 12 US cases of Cerebral Venous Sinus (CVST) with thrombocytopenia after Ad26.COV2.S (Janssen/Johnson & Johnson) vaccination represent serious events. This case series may inform clinical guidance as Ad26.COV2.S... read more

Simulated Identification of Silent COVID-19 Infections Among Children

Simulated Identification of Silent COVID-19 Infections Among Children

In this simulation modeling study of a synthetic US population, in the absence of vaccine availability for children, a targeted approach to rapidly identify silent COVID-19 infections in this age group was estimated to significantly... read more

Understanding The Links Between COVID-19 Vaccines and Thrombosis

Understanding The Links Between COVID-19 Vaccines and Thrombosis

The Advisory Committee on Immunization Practices (ACIP) is convening an emergency meeting to discuss adverse events that recently led to thrombotic events in 6 women administered the Johnson & Johnson COVID-19 vaccine in... read more

COVID-19 vaccines effective for pregnant women, likely protect their babies too

COVID-19 vaccines effective for pregnant women, likely protect their babies too

COVID-19 mRNA vaccines are extremely effective at protecting pregnant and lactating women against the virus, and likely provide protection for their babies as well, according to a study published March 25 in the American... read more

Vaccine-Induced Prothrombotic Immune Thrombocytopenia After AstraZeneca COVID-19 Vaccination

Vaccine-Induced Prothrombotic Immune Thrombocytopenia After AstraZeneca COVID-19 Vaccination

The United Kingdom, European Union, and Scandinavian countries have reported that the AstraZeneca COVID-19 vaccine appears to be associated with rare cases of serious blood clots, including blood clots in the brain. These... read more

The COVID-19 Vaccine: An Expert’s Medical Guide for All

The COVID-19 Vaccine: An Expert’s Medical Guide for All

Vaccine expert Zeil Rosenberg, M.D. shares his medical knowledge, backed by scientific data, about the development, safety and effectiveness of the new COVID-19 vaccines. Dr. Rosenberg M.D. is a Board-Certified Preventive... read more